Two MSCs lead cell-based therapy

Challenge with Mesenchymal Stem Cells and Marrow Stromal Cells

¥²¥¹¥È¥Ö¥Ã¥¯

2242e46801e5446f91e926734e6f890fbdb29ae5

Åê¹Æ¿ô:46·ï

¿·µ¬ºîÀ®

ºîÀ®¡§
½¤Àµ¡§
̾Á° ¥Ñ¥¹¥ï¡¼¥É ¥Ö¥í¥°

Åê¹Æ

¤³¤ó¤Ð¤ó¤Ï¥ì¥¤¤Ç¤¹¡ª»ä¤Î¥Ö¥í¥°¤òˬÌ䤷¤Æ¤¯¤ì¤¿¤ß¤¿¤¤¤Ç¤¹¤Í¡¢¤¢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£Îɤ«¤Ã¤¿¤é¤Þ¤¿Í·¤Ó¤ËÍè¤Æ¤¯¤À¤µ¤¤¤Í¡£

³«¤¯ ¥³¥á¥ó¥È¡Ê0¡Ë

¤¤¤Ä¤â¤ª±Û¤·¤¤¤¿¤À¤­¤¢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£
­¡»ä¤Î¥Ö¥í¥°¤Ç¤¹¤¬¡¢½ñ¸ËÍó¡ÊÆÃ½¸¤ò½ü¤¯¡Ë¤«¤éÆþ¤ê¤Þ¤¹¤È»þ´Ö
¤¬¤«¤«¤ê¡¢¤ªË¾¤ß¤Î¤ª²Ö¤Ë¤¿¤É¤êÃ夯¤Î¤¬ÂçÊѤǤ·¤¿¡£¤³¤ì¤«¤é
¤Ï½ñ¸ËÍó¤ÎÌܼ¡¤«¤é¤ªÆþ¤ê¤¤¤¿¤À¤­¤Þ¤¹¤È¡¢¤½¤ÎÌܼ¡¤Î¤´´õ˾¤Î
¤ª²Ö¤Ø¤Î¥¯¥ê¥Ã¥¯¤Ç¡¢¤¹¤Ð¤ä¤¯¤´´õ˾¤Î¤ª²Ö¤Î²èÁü¤Ë¥ê¥ó¥¯¤Ç¤­
¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤·¤¿¡£º£¤Þ¤Ç»þ´Ö¤¬¤«¤«¤êí´í°¤µ¤ì¤Æ¤¤¤¿Êý¡¢¤ª
º¤¤êÊý¡¢¤É¤¦¤¾¤ª»î¤·²¼¤µ¤¤¡£
­¢¥Ö¥í¥°Â¼¤Ø¤Î¤´¶¨ÎϤ¢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£ºÇ¶á¥Ý¥¤¥ó¥È¤¬Âç
ÊÑ¥À¥¦¥ó¤·¤Æ¤ª¤ê¤Þ¤¹¡£¶²½Ì¤Ç¤¹¤¬¤â¤¦°ìÅ٤ߤʤµ¤Þ¤Î¡¢¤µ¤é¤Ê
¤ë±þ±ç¤¬¤¤¤¿¤À¤±¤ì¤Ð¤¢¤ê¤¬¤¿¤¯»×¤¤¤Þ¤¹¡£¤Ê¤ª¡¢½ç°Ì¤ÏËèÆüÊÑ
¤ï¤ê¤Þ¤¹¡£¤Ê¤ª°ìÁؤΤª°ú¤­Î©¤Æ¤¯¤À¤µ¤¤¤Þ¤¹¤è¤¦¡¢½Å¤Í¤Æ¤ª´ê
¤¤Ãפ·¤Þ¤¹¡£º£¸å¤È¤â¤É¤¦¤¾¤è¤í¤·¤¯¤ª´ê¤¤¤·¤Þ¤¹¡£

³«¤¯ ¥³¥á¥ó¥È¡Ê0¡Ë

¤¤¤Ä¤â¤ª±Û¤·¤¤¤¿¤À¤­¤¢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£ÀèÆü¤ª»Ç¤¤¤·¤Æ¤´
¶¨ÎϤò¤ª´ê¤¤¤·¤Þ¤·¤¿¡É¤Ë¤Û¤ó¥Ö¥í¥°Â¼µ¨Àá¤Î²Ö¡É¤Ë¤ª¤­¤Þ¤·¤Æ
³§ÍͤΤªÎÏź¤¨¤Ë¤è¤ê£¸·î£²£±Æü£²£²¡§£°£µ¸½ºßÂè°ì°Ì¤È¤Ê¤ê¤Þ
¤·¤¿¡£¤Û¤ó¤È¤¦¤Ë¤¢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤·¤¿¡£¤³¤Î½ç°Ì¤ÏËèÆüÊѤï
¤ê¤Þ¤¹¤Î¤Ç¡¢¤Ê¤ª°ìÁؤΤª°ú¤­Î©¤Æ¤¯¤À¤µ¤¤¤Þ¤¹¤è¤¦¤ª´ê¤¤Ãפ·
¤Þ¤¹¡£¤ª±Û¤·¤ÎÀޤˤϡ¢¥Ö¥í¥°Â¼¤Ø¤Î¥¯¥ê¥Ä¥¯¤ò¤è¤í¤·¤¯¤ª´ê¤¤
¤·¤Þ¤¹¡£¥¯¥ê¥Ã¥¯Àè¤Ç¤Ï¡¢µ¨Àá¤Î²Ö¤Î¥Ö¥í¥°¤ÎåºÎï¤Ê¤ª²Ö¤ò¤ªÃÎ
¤é¤»¤¹¤ë¤è¤¦¤Ë¤·¤Æ¤¤¤Þ¤¹¡£º£¸å¤È¤â¤É¤¦¤¾¤è¤í¤·¤¯¤ª´ê¤¤¤·¤Þ
¤¹¡£

³«¤¯ ¥³¥á¥ó¥È¡Ê0¡Ë

¤´Ìµº»ÂÁ¤·¤Æ¤¤¤Þ¤¹¡£¤¤¤Ä¤â¤ª±Û¤·¤¤¤¿¤À¤­¤¢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£¤¤¤Þ¤Þ¤ÇËèÆü¥¢¥Ã¥×¤·¤Æ¤Þ¤¤¤ê¤Þ¤·¤¿¤¬»ö¾ð¤Ë¤è¤êËè¿åÍËÆü
¥¢¥Ã¥×¤òµÙ¤Þ¤»¤Æ¤¤¤¿¤À¤­¤Þ¤¹¡£¤Ê¤ª¡¢¸½ºß¡É¥Ö¥í¥°Â¼µ¨Àá¤Î²Ö¡É¤Ë»²²Ã¤·¤Æ¤ª¤ê¤Þ¤¹¡£¤ª±Û¤·¤ÎÀÞ¤Ë¤Ï¥Ö¥í¥°Â¼µ¨Àá¤Î²Ö¤Ë¤ªÎ©¤Á´ó¤ê¤¤¤¿¤À¤­±þ±ç¤·¤Æ¤¤¤¿¤À¤±¤ì¤Ð¤¢¤ê¤¬¤¿¤¯»×¤¤¤Þ¤¹¡£¤É¤¦¤¾µ¹¤·¤¯¤ª´ê¤¤Ãפ·¤Þ¤¹¡£¤Þ¤¿¤Î¤ª±Û¤·¤ò¤ªÂÔ¤Á¤·¤Æ¤¤¤Þ¤¹¡£

³«¤¯ ¥³¥á¥ó¥È¡Ê0¡Ë


.
Aki¡¡....  Akihiro Umezawa
Aki¡¡.... Akihiro Umezawa
ÃËÀ­ / A·¿
¿Íµ¤ÅÙ
Yahoo!¥Ö¥í¥°¥Ø¥ë¥× - ¥Ö¥í¥°¿Íµ¤Å٤ˤĤ¤¤Æ

¥Ö¥í¥°¥Ð¥Ê¡¼

¸¡º÷ ¸¡º÷
Æü ·î ²Ð ¿å ÌÚ ¶â ÅÚ
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

¤è¤·¤â¤È¥Ö¥í¥°¥é¥ó¥­¥ó¥°

¤â¤Ã¤È¸«¤ë

[PR]¤ªÆÀ¾ðÊó

¤¤¤Þ¤Ê¤é¤â¤é¤¨¤ë¡ª¥¦¥£¥¹¥Ñ¡¼£×¥¬¡¼¥É
Çö¤¤¤·¥â¥ì¤òËɤ°¥Ñ¥ó¥Æ¥£¥é¥¤¥Ê¡¼
ÏÃÂê¤Î¿·À½Éʤò10,000̾Íͤ˥ץ쥼¥ó¥È
¤Õ¤ë¤µ¤ÈǼÀÇ¥µ¥¤¥È¡Ø¤µ¤È¤Õ¤ë¡Ù
¼Â¼Á2000±ß¤ÇÆÃ»ºÉʤ¬¤ª¼ê¸µ¤Ë
11¡¿30¤Þ¤Ç¥­¥ã¥ó¥Ú¡¼¥ó¼Â»ÜÃæ¡ª
¤¤¤Þ¤Ê¤é¤â¤é¤¨¤ë¡ª¥¦¥£¥¹¥Ñ¡¼¤¦¤¹¤µ¤é
Çö¤¤¤·¥â¥ì¤òËɤ°Ç¢¥±¥¢¥Ñ¥Ã¥É
ÏÃÂê¤Î¿·À½Éʤò10,000̾Íͤ˥ץ쥼¥ó¥È

¤½¤Î¾¤Î¥­¥ã¥ó¥Ú¡¼¥ó


¤ß¤ó¤Ê¤Î¹¹¿·µ­»ö